Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
Intervalo de ano de publicação
1.
Oncogene ; 29(9): 1394-404, 2010 Mar 04.
Artigo em Inglês | MEDLINE | ID: mdl-19946337

RESUMO

Increased activity of MYC protein-family members is a common feature in many cancers. Using neuroblastoma as a tumor model, we established a microRNA (miRNA) signature for activated MYCN/c-MYC signaling in two independent primary neuroblastoma tumor cohorts and provide evidence that c-MYC and MYCN have overlapping functions. On the basis of an integrated approach including miRNA and messenger RNA (mRNA) gene expression data we show that miRNA activation contributes to widespread mRNA repression, both in c-MYC- and MYCN-activated tumors. c-MYC/MYCN-induced miRNA activation was shown to be dependent on c-MYC/MYCN promoter binding as evidenced by chromatin immunoprecipitation. Finally, we show that pathways, repressed through c-MYC/MYCN miRNA activation, are highly correlated to tumor aggressiveness and are conserved across different tumor entities suggesting that c-MYC/MYCN activate a core set of miRNAs for cooperative repression of common transcriptional programs related to disease aggressiveness. Our results uncover a widespread correlation between miRNA activation and c-MYC/MYCN-mediated coding gene expression modulation and further substantiate the overlapping functions of c-MYC and MYCN in the process of tumorigenesis.


Assuntos
Regulação Neoplásica da Expressão Gênica/fisiologia , Redes Reguladoras de Genes/efeitos dos fármacos , Genes myc/fisiologia , MicroRNAs/farmacologia , Neuroblastoma/genética , Proteínas Nucleares/farmacologia , Proteínas Oncogênicas/farmacologia , Regiões Promotoras Genéticas/efeitos dos fármacos , Linhagem Celular Tumoral , Redes Reguladoras de Genes/fisiologia , Inativação Gênica/fisiologia , Genes myc/genética , Humanos , MicroRNAs/biossíntese , Proteína Proto-Oncogênica N-Myc , Neuroblastoma/terapia , RNA Interferente Pequeno/farmacologia , Fatores de Transcrição/fisiologia , Resultado do Tratamento
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA